Product Program year 2019 Source: CMS Open Payments

Bb-2121

Drug

Open in the dashboard

General payments

$231,662

273 payments

Research payments

$11,225,161

61 payments

Through program year 2019, $231,662 in general payments and $11,225,161 in research payments were reported against Bb-2121.

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

2 rows
Year Kind Amount Payments
2019 General $231,662 273
2019 Research $11,225,161 61

Breakdown

Who paid General payments · program year 2019
  1. Celgene Corporation $231,662 273 payments
Top recipients General payments · program year 2019
  1. Deepu Madduri Hematology · Stanford, CA $17,026 7% · 14 payments
  2. Matthew Lunning Medical Oncology · Omaha, NE $9,593 4% · 11 payments
  3. Raymond Thertulien Hematology · Charlotte, NC $8,239 4% · 8 payments
  4. Jesus Berdeja Hematology & Oncology · Nashville, TN $8,211 4% · 7 payments
  5. Melissa Alsina Hematology · Tampa, FL $7,807 3% · 7 payments

The top 5 of 40 recipients; each share is of general payments naming this product in 2019.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2019
  1. Hematology & Oncology Internal Medicine $110,759 48% · 22 practitioners
  2. Medical Oncology Internal Medicine $46,532 20% · 8 practitioners
  3. Hematology Internal Medicine $35,097 15% · 4 practitioners
  4. Pediatrics $14,472 6% · 2 practitioners
  5. Internal Medicine $7,767 3% · 1 practitioner

The top 5 of 8 specialties; each share is of general payments naming this product to practitioners with a specialty in 2019. Each practitioner is counted under their primary specialty.

The top 25 specialties, free in the app

Where the money went General payments · program year 2019
  1. New York $37,704 16% · 6 recipients
  2. Arizona $24,867 11% · 4 recipients
  3. Florida $24,414 11% · 4 recipients
  4. Michigan $16,672 7% · 3 recipients
  5. Nebraska $15,921 7% · 2 recipients

The top 5 of 21 states; each share is of general payments naming this product in 2019 where a state was reported.

The top 25 states, free in the app

273 general · 61 research

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2019

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record